would you like to finance the development of highly active antiviral drugs?
Please give us a call! Our hotline is available: +49 176 2198 1495 und +49 176 2198 1496 Monday 10 am – 11 am CEST Wednesday 10 am – 11 am CEST Friday 10 am – 11 am, and 3 pm – 4 pm CEST fax +49 2471 1356 067 E-mail: breun@sajo-innovation.com and baumann@sajo-innovation.com Beyond […]
summer 2020 in Germany
…an outlook into the coming months with SARS-CoV-2 First, we want to point to our recent blog post, where we described how the pandemic is gaining traction worldwide. In several countries, such as the U.S., Mexico, Brazil, India, South Africa, Iran, and Saudi Arabia it is reaching dimensions of human tragedies. Too many politicians in […]
COVID-19 accelerates: hit! sunken?
SARS-CoV-2 update As of today, according to the Johns Hopkins University there are more than 12 M confirmed SARS-CoV-2 infections globally. More than 500,000 people have died of COVID-19. The number of unreported cases is expected to be much higher, since for example people who died “with” COVID-19 are not part of this statistics. Countries […]
vaccine strategies against SARS-CoV-2
… an overview … Currently, numerous trials are under way globally to obtain a vaccine against SARS-CoV-2. As of June, there are 13 candidate vaccines undergoing first clinical trials, a further 126 candidates are in preclinical examination (WHO, June 9, 2020). Four aspects are important in the current vaccine race: The vaccine needs to be […]
